Skip to Main Content


Skip Nav Destination

Abstract 1386: Safety and tolerability of guadecitabine (SGI-110) plus cisplatin in patients with platinum refractory germ cell tumors (GCT): A phase 1 study

Cancer Res (2018) 78 (13_Supplement): 1386.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal